BioLife Solutions (BLFS) News Today $25.01 +2.57 (+11.45%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BioLife Solutions (NASDAQ:BLFS) Given New $27.00 Price Target at HC WainwrightNovember 21 at 2:45 AM | americanbankingnews.comResearch Analysts Issue Forecasts for BLFS Q1 EarningsBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for BioLife Solutions in a report released on Monday, November 18th. HC Wainwright analyst Y. Chen expects that the medical equipment provider will postNovember 20 at 6:58 AM | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 17,604 SharesNovember 20 at 5:47 AM | insidertrades.comBioLife Solutions (NASDAQ:BLFS) Shares Gap Down on Analyst DowngradeNovember 20 at 1:15 AM | americanbankingnews.comAnalyst Expectations For BioLife Solns's FutureNovember 18 at 7:55 PM | benzinga.comBioLife Solutions price target lowered to $27 from $29 at H.C. WainwrightNovember 18 at 7:55 PM | markets.businessinsider.comBioLife Solutions: Strategic Refocus and Strong Q3 Performance Bolster Buy Rating with $27 Price TargetNovember 18 at 7:55 PM | markets.businessinsider.comBioLife Solutions (NASDAQ:BLFS) Shares Gap Down Following Analyst DowngradeBioLife Solutions (NASDAQ:BLFS) Shares Gap Down Following Analyst DowngradeNovember 18 at 10:43 AM | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Price Target Cut to $27.00 by Analysts at HC WainwrightHC Wainwright decreased their price target on BioLife Solutions from $29.00 to $27.00 and set a "buy" rating on the stock in a research note on Monday.November 18 at 8:11 AM | marketbeat.comFY2024 EPS Forecast for BioLife Solutions Lifted by AnalystNovember 18 at 3:03 AM | americanbankingnews.comWhat is Northland Capmk's Forecast for BLFS FY2024 Earnings?BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Northland Capmk increased their FY2024 earnings per share estimates for BioLife Solutions in a research report issued to clients and investors on Wednesday, November 13th. Northland Capmk analyst C. Byrnes now anticipates that the medical equiNovember 18 at 2:30 AM | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Just Reported And Analysts Have Been Cutting Their EstimatesNovember 16, 2024 | finance.yahoo.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Royce & Associates LPRoyce & Associates LP decreased its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 9.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 825,133 shares of the medical equipment provider'November 16, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Price Target Raised to $32.00 at Craig HallumNovember 15, 2024 | americanbankingnews.comBioLife Solutions Reports Strong Q3 2024 ResultsNovember 15, 2024 | markets.businessinsider.comBioLife Solutions Sells Custom Biogenic Systems Freezer SubsidiaryNovember 14, 2024 | marketwatch.comBioLife Solutions announces $6.1M sale of freezer subsidiary, Arctic SolutionsNovember 14, 2024 | markets.businessinsider.comBioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer SubsidiaryNovember 14, 2024 | prnewswire.comBioLife Solutions, Inc.: BioLife Solutions Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deNorthland Securities Sticks to Their Buy Rating for BioLife Solutions (BLFS)November 13, 2024 | markets.businessinsider.comBioLife Solutions Inc (BLFS) Q3 2024 Earnings Call Highlights: Strategic Divestitures and ...November 13, 2024 | finance.yahoo.comBioLife Solutions price target raised to $31 from $28 at TD CowenNovember 13, 2024 | markets.businessinsider.comBioLife Solutions: Strategic Refocus and Strong Financial Performance Justify Buy RatingNovember 13, 2024 | markets.businessinsider.comBioLife Solutions (BLFS) Gets a Buy from Lake StreetNovember 13, 2024 | markets.businessinsider.comBioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comBioLife Solutions Reports Third Quarter 2024 Financial ResultsNovember 12, 2024 | prnewswire.comBioLife Solutions (NASDAQ:BLFS) Reaches New 1-Year High - What's Next?BioLife Solutions (NASDAQ:BLFS) Sets New 52-Week High - Still a Buy?November 12, 2024 | marketbeat.comBioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage SubsidiaryNovember 12, 2024 | prnewswire.comWhat To Expect From BioLife Solutions Inc (BLFS) Q3 2024 EarningsNovember 11, 2024 | uk.finance.yahoo.comBioLife Solutions (BLFS) Set to Announce Quarterly Earnings on TuesdayBioLife Solutions (NASDAQ:BLFS) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=643490)November 5, 2024 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Rating of "Buy" by AnalystsBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has received an average rating of "Buy" from the six analysts that are presently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price objective among analystNovember 4, 2024 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells 547 Shares of StockNovember 2, 2024 | insidertrades.comAby J. Mathew Sells 547 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 547 shares of the company's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $23.15, for a total transaction of $12,663.05. Following the completion of the transaction, the executive vice president now owns 317,169 shares of the company's stock, valued at $7,342,462.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.November 1, 2024 | marketbeat.comBioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024October 31, 2024 | prnewswire.comAllspring Global Investments Holdings LLC Trims Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Allspring Global Investments Holdings LLC decreased its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 17.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 111,114 shares of the medicaOctober 30, 2024 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Share Price Crosses Above 200-Day Moving Average - Should You Sell?BioLife Solutions (NASDAQ:BLFS) Stock Crosses Above 200-Day Moving Average - What's Next?October 26, 2024 | marketbeat.comAby J. Mathew Sells 10,000 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockOctober 18, 2024 | insidertrades.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells 10,000 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 10,000 shares of the business's stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $23.28, for a total value of $232,800.00. Following the completion of the transaction, the executive vice president now directly owns 317,716 shares in the company, valued at $7,396,428.48. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.October 17, 2024 | marketbeat.comBioLife Solns (NASDAQ:BLFS) Stock, Insider Trading ActivityOctober 17, 2024 | benzinga.comRenaissance Technologies LLC Buys Shares of 28,700 BioLife Solutions, Inc. (NASDAQ:BLFS)Renaissance Technologies LLC bought a new stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 28,700 shares of the medical equipment providerOctober 10, 2024 | marketbeat.comBioLife Solutions Inc (BLFS) Q2 2024 Earnings Call Highlights: Navigating Challenges with ...October 9, 2024 | finance.yahoo.com48,596 Shares in BioLife Solutions, Inc. (NASDAQ:BLFS) Bought by Squarepoint Ops LLCSquarepoint Ops LLC acquired a new stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 48,596 shares of the medical equipment proviOctober 7, 2024 | marketbeat.comBard Financial Services Inc. Sells 36,825 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)Bard Financial Services Inc. decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 19.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 153,475 shares of the medical equipmentOctober 5, 2024 | marketbeat.comHC Wainwright & Co. Initiates Coverage of BioLife Solutions (BLFS) with Buy RecommendationOctober 1, 2024 | msn.comBioLife Solutions, Inc. (NASDAQ:BLFS) to Post Q3 2024 Earnings of ($0.09) Per Share, HC Wainwright ForecastsBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - HC Wainwright issued their Q3 2024 EPS estimates for BioLife Solutions in a report released on Monday, September 30th. HC Wainwright analyst Y. Chen anticipates that the medical equipment provider will post earnings per share of ($0.09) for thOctober 1, 2024 | marketbeat.comKey Takeaways From BioLife Solns Analyst RatingsSeptember 30, 2024 | benzinga.comBioLife Solutions: A ‘Buy’ Rating for its Strategic Positioning in the Expanding CGT MarketSeptember 30, 2024 | markets.businessinsider.comBioLife Solutions (NASDAQ:BLFS) Coverage Initiated by Analysts at HC WainwrightHC Wainwright assumed coverage on shares of BioLife Solutions in a report on Monday. They issued a "buy" rating and a $29.00 target price on the stock.September 30, 2024 | marketbeat.comCasdin Capital, LLC Increases Stake in Codexis IncSeptember 26, 2024 | finance.yahoo.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Purchased by Fred Alger Management LLCFred Alger Management LLC boosted its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 6.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,579,138 shares of the medical equipmSeptember 25, 2024 | marketbeat.com Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! BLFS Media Mentions By Week BLFS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLFS News Sentiment▼0.490.46▲Average Medical News Sentiment BLFS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLFS Articles This Week▼283▲BLFS Articles Average Week Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zynex News Today Outset Medical News Today Axonics News Today Envista News Today Inari Medical News Today LivaNova News Today TransMedics Group News Today Enovis News Today iRhythm Technologies News Today Warby Parker News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLFS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
